(1)
Deep Learning and Inflammatory Markers Predict Early Response to Immunotherapy in Unresectable NSCLC: A Multicenter Study. Biomol Biomed 2025, 25 (10), 2252–2268. https://doi.org/10.17305/bb.2025.12324.